Molecular determinants of state-dependent block of voltage-gated sodium channels by pilsicainide
Open Access
- 26 April 2010
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 160 (6), 1521-1533
- https://doi.org/10.1111/j.1476-5381.2010.00816.x
Abstract
Background and purpose: Pilsicainide, an anti-arrhythmic drug used in Japan, is described as a pure sodium channel blocker.ud We examined the mechanisms by which it is able to block open channels, because these properties may be especially useful to reduce hyperexcitability in pathologies characterized by abnormal sodium channel opening.ud Experimental approach: The effects of pilsicainide on various heterologously expressed human sodium channel subtypes andud mutants were investigated using the patch clamp technique.ud Key results: Pilsicainide exhibited tonic and use-dependent effects comparable to those of mexiletine and flecainide on hNav1.4 channels. These use-dependent effects were abolished in the mutations F1586C and Y1593C within segment 6 of domain IV, suggesting that the interaction of pilsicainide with these residues is critical for its local anaesthetic action. Its affinity constants for closed channels (KR) and channels inactivated from the closed state (KI) were high, suggesting that its use-dependent block (UDB) requires the channel to be open for it to reach a high-affinity blocking site. Accordingly, basic pH,ud which slightly increased the proportion of neutral drug, dramatically decreased KR and KI values. Effects of pilsicainide were similar on skeletal muscle hNav1.4, brain hNav1.1 and heart hNav1.5 channels. The myotonic R1448C and G1306E hNav1.4 mutants were more and less sensitive to pilsicainide, respectively, due to mutation-induced gating modifications.ud Conclusions and implications: Although therapeutic concentrations of pilsicainide may have little effect on resting and closed-state inactivated channels, it induces a strong UDB due to channel opening, rendering the drug ideally suited forud inhibition of high-frequency action potential firingKeywords
This publication has 53 references indexed in Scilit:
- Using Lidocaine and Benzocaine to Link Sodium Channel Molecular Conformations to State-Dependent Antiarrhythmic Drug AffinityCirculation Research, 2009
- Guide to Receptors and Channels (GRAC), 3rd editionBritish Journal of Pharmacology, 2008
- Charge at the lidocaine binding site residue Phe‐1759 affects permeation in human cardiac voltage‐gated sodium channelsThe Journal of Physiology, 2007
- International Union of Pharmacology. XLVII. Nomenclature and Structure-Function Relationships of Voltage-Gated Sodium ChannelsPharmacological Reviews, 2005
- Inherited disorders of voltage-gated sodium channelsJCI Insight, 2005
- Closing and Inactivation Potentiate the Cocaethylene Inhibition of Cardiac Sodium Channels by Distinct MechanismsMolecular Pharmacology, 2003
- PH-metric logP 11. pKa determination of water-insoluble drugs in organic solvent–water mixturesJournal of Pharmaceutical and Biomedical Analysis, 1999
- Uniqueness of Pilsicainide in Class Ic Antiarrhythmics.Japanese Heart Journal, 1998
- Pilsicainide, a New Class I Antiarrhythmic DrugCardiovascular Drug Reviews, 1993
- Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channelsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1977